AAAAAA
Results:
1-17
|
Results: 17
Authors:
Adjei, AA
Davis, JN
Bruzek, LM
Erlichman, C
Kaufmann, SH
Citation: Aa. Adjei et al., Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines, CLIN CANC R, 7(5), 2001, pp. 1438-1445
Authors:
Davis, JN
Kucuk, O
Djuric, Z
Sarkar, FH
Citation: Jn. Davis et al., Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes, FREE RAD B, 30(11), 2001, pp. 1293-1302
Authors:
Joffs, C
Walker, CA
Hendrick, JW
Fary, DJ
Almany, DK
Davis, JN
Goldberg, AT
Crawford, FA
Spinale, FG
Citation: C. Joffs et al., Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass, J THOR SURG, 122(2), 2001, pp. 365-370
Authors:
Adjei, AA
Davis, JN
Erlichman, C
Svingen, PA
Kaufmann, SH
Citation: Aa. Adjei et al., Comparison of potential markers of farnesyltransferase inhibition, CLIN CANC R, 6(6), 2000, pp. 2318-2325
Authors:
Davis, JN
Muqim, N
Bhuiyan, M
Kucuk, O
Pienta, KJ
Sarkar, FH
Citation: Jn. Davis et al., Inhibition of prostate specific antigen expression by genistein in prostate cancer cells, INT J ONCOL, 16(6), 2000, pp. 1091-1097
Authors:
Buijs, A
van Rompaey, L
Molijn, AC
Davis, JN
Vertegaal, ACO
Potter, MD
Adams, C
van Baal, S
Zwarthoff, EC
Roussel, MF
Grosveld, GC
Citation: A. Buijs et al., The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity, MOL CELL B, 20(24), 2000, pp. 9281-9293
Authors:
Davis, JN
Citation: Jn. Davis, A few tips on hypothesis testing, BEHAV BRAIN, 23(4), 2000, pp. 600
Authors:
Shyng, SL
Barbieri, A
Gumusboga, A
Cukras, C
Pike, L
Davis, JN
Stahl, PD
Nichols, CG
Citation: Sl. Shyng et al., Modulation of nucleotide sensitivity of ATP-sensitive potassium channels by phosphatidylinositol-4-phosphate 5-kinase, P NAS US, 97(2), 2000, pp. 937-941
Authors:
Adjei, AA
Erlichman, C
Davis, JN
Cutler, DL
Sloan, JA
Marks, RS
Hanson, LJ
Svingen, PA
Atherton, P
Bishop, WR
Kirschmeier, P
Kaufmann, SH
Citation: Aa. Adjei et al., A Phase I trial of the farnesyl transferase inhibitor SCH66336: Evidence for biological and clinical activity, CANCER RES, 60(7), 2000, pp. 1871-1877
Authors:
Davis, JN
Todd, PM
Bullock, S
Citation: Jn. Davis et al., Environment quality predicts parental provisioning decisions, P ROY SOC B, 266(1430), 1999, pp. 1791-1797
Authors:
Davis, JN
Williams, BJ
Herron, JT
Galiano, FJ
Meyers, S
Citation: Jn. Davis et al., ETO-2, a new member of the ETO-family of nuclear proteins, ONCOGENE, 18(6), 1999, pp. 1375-1383
Authors:
Davis, JN
Kucuk, O
Sarkar, FH
Citation: Jn. Davis et al., Genistein inhibits NF-kappa B activation in prostate cancer cells, NUTR CANCER, 35(2), 1999, pp. 167-174
Authors:
Parker, WD
Swerdlow, RH
Parks, JK
Davis, JN
Trimmer, P
Bennett, JP
Wooten, GF
Citation: Wd. Parker et al., Parkinson disease in twins, J AM MED A, 282(14), 1999, pp. 1328-1328
Authors:
Davis, JN
Chisholm, JC
Citation: Jn. Davis et Jc. Chisholm, Alois Alzheimer and the amyloid debate, NATURE, 400(6747), 1999, pp. 810-810
Authors:
Antonawich, FJ
Federoff, HJ
Davis, JN
Citation: Fj. Antonawich et al., BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia, EXP NEUROL, 156(1), 1999, pp. 130-137
Authors:
Swerdlow, RH
Parks, JK
Davis, JN
Cassarino, DS
Trimmer, PA
Currie, LJ
Dougherty, J
Bridges, WC
Bennett, JP
Wooten, GF
Parker, WD
Citation: Rh. Swerdlow et al., Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family, ANN NEUROL, 44(6), 1998, pp. 873-881
Authors:
Davis, JN
Singh, B
Bhuiyan, M
Sarkar, FH
Citation: Jn. Davis et al., Genistein-induced upregulation of p21(WAF1), downregulation of cyclin B, and induction of apoptosis in prostate cancer cells, NUTR CANCER, 32(3), 1998, pp. 123-131
Risultati:
1-17
|